News

01/04/2025

Identifying the Factors That Accelerate Full FDA Approval of Oncology Drugs

A study led by Dr. Ariadna Tibau, researcher at the Sant Pau Research Institute (IR Sant Pau) and oncologist at Hospital de Sant Pau, was recently published in the journal JAMA Network Open. The artic...

31/03/2025

A Targeted Nanotoxin Activates the Immune Response and Slows Colorectal Cancer Growth in Preclinical Models

Researchers from the Sant Pau Research Institute (IR Sant Pau) have demonstrated, in a preclinical study, the effectiveness of a targeted nanotoxin in inhibiting colorectal cancer growth. The study, p...

31/03/2025

Dapagliflozin Improves Heart Failure Treatment in Older Patients with Aortic Stenosis

The Sant Pau Research Institute (IR Sant Pau), together with the Hospital de Sant Pau, has participated in the DapaTAVI clinical trial, which has shown that the use of the drug dapagliflozin significa...

28/03/2025

Epigenetics Key to Understanding Stroke Risk and Recovery

The Pharmacogenomics and Neurovascular Genetics Group at the Sant Pau Research Institute (IR Sant Pau) has been invited to contribute to a special issue of the Journal of Cerebral Blood Flow & Met...

28/03/2025

IR Sant Pau Hosts Key Conference on Technological Advancements in GMP Environments as Part of the TERAV Network

On Wednesday, March 26, the Sant Pau Research Institute (IR Sant Pau) hosted the conference about technological advancements for manufacturing in a Good Manufacturing Pratice (GMP) environment, a spec...